[Left atrial appendage in rheumatic mitral valve disease: The main source of embolism in atrial fibrillation]

Ovidio A García-Villarreal1, José A Heredia-Delgado1

  • 1Departamento de Cirugía Cardiaca, Hospital de Cardiología UMAE 34, Instituto Mexicano del Seguro Social, , Monterrey, Nuevo León, México.

Insights

Surgical removal of the left atrial appendage in patients with rheumatic mitral valve disease and persistent atrial fibrillation may eliminate stroke risk and the need for anticoagulation. This procedure targets a potential source of emboli, improving patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Vascular Surgery

Background:

  • Rheumatic mitral valve disease (RMVD) and persistent atrial fibrillation (AF) increase stroke risk.
  • The left atrial appendage (LAA) is a potential source of thromboembolism in AF patients.
  • Long-term oral anticoagulation is often required but carries bleeding risks.

Purpose of the Study:

  • To evaluate the efficacy of LAA resection in reducing stroke incidence in RMVD patients with persistent AF.
  • To assess the feasibility of discontinuing oral anticoagulation post-LAA resection.
  • To investigate the association between LAA thrombi and embolic events.

Main Methods:

  • A prospective observational study of 27 adult patients undergoing mitral valve surgery and LAA resection.
  • Oral anticoagulation was ceased 3 months post-surgery.
  • Outcomes included absence of embolic stroke and assessment of postoperative LAA embolism via echocardiography.

Main Results:

  • No embolic strokes occurred after 3 months post-surgery.
  • One transient ischemic attack (TIA) occurred while on warfarin pre-operatively.
  • Pre-operative LAA thrombi were identified in 40.7% of patients, with 54.5% of these having a history of embolic stroke.

Conclusions:

  • LAA resection may be a primary strategy to prevent stroke in RMVD patients with persistent AF.
  • Eliminating the LAA could negate the need for long-term anticoagulation.
  • The LAA is a significant source of emboli in this patient population.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
711
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
848
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
399
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
807
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
820